The facility, run by the Essential Drugs Company Limited, has a target of producing 2.16 crore bottles of IV fluids annually. Trial production has already begun, and full-scale commercial operations are expected to start by the end of this month
from The Business Standard https://ift.tt/c9Y5MbJ

0 Comments